Diagnostics
Rapid HIV test modified to detect recent seroconversion
Published in TB and Outbreaks Week, September 27th, 2005
"Assay protocols of three rapid human immunodeficiency virus (HIV) assays, OraQuick-1/2, SeroStrip-1/2, and Determine-1/2, were modified to detect recent HIV seroconversion using a higher dilution of serum specimens.
"Optimal predilution of specimens resulted in negative test results during early periods of seroconversion (about 6 months), when antibody levels were low," scientists in the United States report.
"A total of 269 seropositive specimens from routine HIV type 1 testing and from commercial sources (low-titer and seroconversion panels) were tested, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diagnostics
Antigens that discriminate between TB and non-TB sera have been identified - Epidemiology
Genital HSV-1 and HSV-2 epidemiology varies between ethnic groups in U.K. - Mycobacterium Fortuitum
Subinhibitory fluoroquinolone dose increases mycobacterial mutation rates - Neonatal Sepsis
Neonatal sepsis associated with bacterial contamination of intravenous fluids - Adverse Drug Reaction
Prolonged linezolid for TB associated with anemia and peripheral neuropathy - Alcohol Use
Alcohol abuse related to risky sex among HIV-positive men who have sex with men - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
